Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 474321 - 474340 out of 483426 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01EB04) osimertinib (adm: O) | TAGRISSO 80MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01EB04) osimertinib (adm: O) | TAGRISSO 80MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01EB07) dacomitinib (adm: O) | VIZIMPRO 15MG FCT 1X30 BTL US | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | Pfizer,Inc. |
| USA | (L01EB07) dacomitinib (adm: O) | VIZIMPRO 15MG FCT 1X30 BTL US | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | Pfizer,Inc. |
| USA | (L01EB07) dacomitinib (adm: O) | VIZIMPRO 30MG FCT 1X30 BTL US | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | Pfizer,Inc. |
| USA | (L01EB07) dacomitinib (adm: O) | VIZIMPRO 30MG FCT 1X30 BTL US | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | Pfizer,Inc. |
| USA | (L01EB07) dacomitinib (adm: O) | VIZIMPRO 45MG FCT 1X30 BTL US | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | Pfizer,Inc. |
| USA | (L01EB07) dacomitinib (adm: O) | VIZIMPRO 45MG FCT 1X30 BTL US | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | Pfizer,Inc. |
| USA | (L01EC01) vemurafenib (adm: O) | ZELBORAF 240MG TAB | 112 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma | GenentechUSA,Inc. |
| USA | (L01EC01) vemurafenib (adm: O) | ZELBORAF 240MG TAB | 112 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma | GenentechUSA,Inc. |
| USA | (L01EC02) dabrafenib (adm: O) | TAFINLAR 50MG CAP | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma | NovartisPharmaceuticalsCorporation |
| USA | (L01EC02) dabrafenib (adm: O) | TAFINLAR 50MG CAP | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma | NovartisPharmaceuticalsCorporation |
| USA | (L01EC02) dabrafenib (adm: O) | TAFINLAR 75MG CAP | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma | NovartisPharmaceuticalsCorporation |
| USA | (L01EC02) dabrafenib (adm: O) | TAFINLAR 75MG CAP | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma | NovartisPharmaceuticalsCorporation |
| USA | (L01EC02) dabrafenib (adm: O) | TAFINLAR 10MG TAB,SUSP,ORAL | 210 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma | NovartisPharmaceuticalsCorporation |
| USA | (L01EC02) dabrafenib (adm: O) | TAFINLAR 10MG TAB,SUSP,ORAL | 210 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma | NovartisPharmaceuticalsCorporation |
| USA | (L01EC03) encorafenib (adm: O) | BRAFTOVI 75MG CAP,ORAL | 2X90 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Colorectal Neoplasms | Pfizer,Inc. |
| USA | (L01EC03) encorafenib (adm: O) | BRAFTOVI 75MG CAP,ORAL | 2X60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Colorectal Neoplasms | Pfizer,Inc. |
| USA | (L01EC03) encorafenib (adm: O) | BRAFTOVI 75MG CAP,ORAL | 2X90 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Colorectal Neoplasms | Pfizer,Inc. |
| USA | (L01EC03) encorafenib (adm: O) | BRAFTOVI 75MG CAP,ORAL | 2X60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Colorectal Neoplasms | Pfizer,Inc. |
Pages
